Delee
Delee, from Mexico, built a blood-testing device that catches circulating tumour cells to help diagnose cancer earlier and follow treatment.
Overview
Delee is a Monterrey-based medical device company whose CytoCatch system isolates and analyses circulating tumour cells from a blood sample for early diagnosis and treatment monitoring. It was one of the first Latin American oncology device companies through YC. The YC directory lists it as active, but the company domain no longer resolved to a company site when checked on 2026-09-10 and no peer-reviewed clinical validation of a marketed test was found, so its current status and evidence should be treated as unverified.
Funding
All startupsPages like this
not linked directly; found by shared links- CompanyAOA Dx
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyCambridge Cancer Genomics (CCG.ai)
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyNumen
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyLiyfe
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.
- CompanyREPROSENT
Shares Y Combinator and the tag yc.
- CompanyBillionToOne
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.